These are our products available in the United Kingdom please click on the name for the SPC and PIL information:

• Alprolix®
• Doptelet® 
• Elocta®
• Kineret®
• Orfadin®
• Tegsedi®
• Waylivra®

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk

Adverse events should also be reported to Swedish Orphan Biovitrum Ltd by email: drugsafety@sobi.com, and for product complaints complaints@sobi.com. Alternatively, they can be reported to Sobi UK Ltd, telephone number +44 1223 891854.